Markets

Novonesis To Acquire Thailand Production Facility For Around $50 Mln

April 08, 2026 — 03:12 am EDT

Written by RTTNews.com for RTTNews

(RTTNews) - Novozymes A/S, Novonesis (NVZMF.PK, NSIS_B.CO, NSIS-B.CO, NVZMF, NSIS-B), a biotechnology company, on Wednesday announced an agreement to acquire a production facility in Rayong, Thailand from Meihua for around $50 million.

The acquisition aims to expand the company's footprint in Southeast Asia and strengthen its global production capabilities.

The facility includes advanced fermentation capabilities and can be further expanded to support growth, including production of human milk oligosaccharides.

The company plans additional investments in the site and expects it to become commercially operational in 2027.

The move supports Novonesis' long-term GROW strategy, with emerging markets accounting for about one-third of its sales and expected to grow faster than developed markets.

Novonesis is currently trading 0.35% lesser at DKK 395 on the Copenhagen Stock Exchange.

RTTNews
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.
More articles by this source

Tags

Markets
Stocks Mentioned

Latest Articles
Data is currently not available